Qualigen Therapeutics’ Partner NanoSynex to Present Technology at BioMed Israel

Go back to Qualigen Therapeutics’ Partner NanoSynex to Present Technology at BioMed Israel
(NASDAQ: QLGN) Delayed: 3.21 --0 (-0%)
Previous Close $3.21    52 Week High
Open $3.21    52 Week Low
Day High $3.21    P/E N/A 
Day Low $3.21    EPS
Volume 10,913